Brian K. Dallaire, Class of 1975Brian K. Dallaire
'75 is the 2007 recipient of Thornton Academy's Distinguished Alumni Award, which is sponsored by the Alumni Association
and recognizes outstanding lifetime achievements of TA graduates in the hope of fostering aspiration in graduating seniors and undergraduates.Brian Dallaire
'75, right, received the Distinguished Alumni Award from Alumni Board Vice President David LePauloue '84 at baccalaureate.
...Dallaire, who received his award May 27 during the baccalaureate ceremony for this year's graduating class, is founder and president of Lighthouse Clinical Development, which specializes in helping the pharmaceutical and biotechnology industries plan strategies for clinical development.He is also a clinical consultant to Aiko Biotechnology, a Maine-based group that is developing drugs to augment morphine for the treatment of pain.Prior to forming his company, Dallaire served as senior director for medical affairs and senior director of clinical trials management at IDEC Pharmaceuticals in San Diego.He
was part of an IDEC
team that developed the drug Rituxan, a genetically engineered antibody used to treat non-Hodgkins lymphoma, as well as rheumatoid arthritis, multiple sclerosis and lupus.Dallaire
was inspired to enter the field of scientific research after his
cousin, Deb Petit, died of cancer when he
was 11 years old.
"My career has taken me to six states and two countries, but I have come full circle to return to my roots here in Maine," Dallaire
told the Class of 2007.
...Dallaire received his bachelor's degree from the University of Rhode Island and his doctorate from the University of Cincinnati Hospital, both in pharmacy.